New Drug Could Lower Risk of Alzheimer's Disease, Study Finds

USC Scientists Unveil 5-in-1 Blood Test for Early Alzheimer’s Detection

In a proof-of-concept study, the test successfully identified five critical biomarkers associated with Alzheimer’s disease, exceeding the capabilities of currently available commercial blood tests. Researchers at the Keck School of Medicine of USC have created a  new blood test that could make it easier to detect Alzheimer’s disease early. This innovative tool, called the Penta-Plex [...]

A common sleep aid blocks neurodegeneration in mice

A common sleep aid restores healthier sleep patterns and protects mice from the brain damage seen in neurodegenerative disorders, such as Alzheimer's disease, according to new research from Washington University School of Medicine in St. Louis. The drug, lemborexant, prevents the harmful buildup of an abnormal form of a protein called tau in the brain, reducing the inflammatory brain damage tau is known to cause in Alzheimer's.

With new Alzheimer’s blood test cleared, a potential vaccine could be on the horizon

Nuravax and others are working on the next wave of Alzheimer’s treatments to catch the disease before symptoms arise.

Groundbreaking blood test trial underway to diagnose dementia

The initiative, led by the READ-OUT research team at Dementias Platform UK (DPUK), aims to improve the UK's dementia diagnosis rate

New drug could lower risk of Alzheimer's disease, study finds

Researchers in a new study found that the drug showed an ability to protect the brain in a certain way, which is a critical defense against Alzheimer’s disease.

Blood test pinpoints early Alzheimer’s risk with high accuracy

Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively unimpaired adults at risk for Alzheimer’s disease. Plasma p-tau217/Aβ42 emerged as the most robust and accurate blood-based marker for identifying preclinical amyloid pathology.